267 related articles for article (PubMed ID: 28631017)
1. Proton therapy of iris melanoma with 50 CGE : Influence of target volume on clinical outcome.
Riechardt AI; Karle B; Cordini D; Heufelder J; Budach V; Joussen AM; Gollrad J
Strahlenther Onkol; 2017 Nov; 193(11):943-950. PubMed ID: 28631017
[TBL] [Abstract][Full Text] [Related]
2. Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects.
Riechardt AI; Klein JP; Cordini D; Heufelder J; Rehak M; Seibel I; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1325-1332. PubMed ID: 29464331
[TBL] [Abstract][Full Text] [Related]
3. Proton beam radiotherapy of diffuse iris melanoma in 54 patients.
Willerding GD; Cordini D; Hackl C; Karle B; Lakotka N; Foerster MH; Bechrakis NN; Heufelder J; Moser L; Joussen AM
Br J Ophthalmol; 2015 Jun; 99(6):812-6. PubMed ID: 25505288
[TBL] [Abstract][Full Text] [Related]
4. Recurrence of iris melanoma after proton beam therapy.
Sandinha MT; Kacperek A; Errington RD; Coupland SE; Damato B
Br J Ophthalmol; 2014 Apr; 98(4):484-7. PubMed ID: 24414401
[TBL] [Abstract][Full Text] [Related]
5. Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors.
Riechardt AI; Pilger D; Cordini D; Seibel I; Gundlach E; Hager A; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2263-2269. PubMed ID: 28721444
[TBL] [Abstract][Full Text] [Related]
6. Whole anterior segment proton beam radiotherapy for diffuse iris melanoma.
Konstantinidis L; Roberts D; Errington RD; Kacperek A; Damato B
Br J Ophthalmol; 2013 Apr; 97(4):471-4. PubMed ID: 23298884
[TBL] [Abstract][Full Text] [Related]
7. Proton beam therapy for iris melanomas.
Lumbroso-Le Rouic L; Delacroix S; Dendale R; Levy-Gabriel C; Feuvret L; Noel G; Plancher C; Nauraye C; Garcia P; Calugaru V; Asselain B; Desjardins L
Eye (Lond); 2006 Nov; 20(11):1300-5. PubMed ID: 16294207
[TBL] [Abstract][Full Text] [Related]
8. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes.
Shields CL; Shah SU; Bianciotto CG; Emrich J; Komarnicky L; Shields JA
Ophthalmology; 2013 Jan; 120(1):55-61. PubMed ID: 22980742
[TBL] [Abstract][Full Text] [Related]
9. Proton beam therapy for iris melanoma: a review of 15 cases.
Rundle P; Singh AD; Rennie I
Eye (Lond); 2007 Jan; 21(1):79-82. PubMed ID: 16410818
[TBL] [Abstract][Full Text] [Related]
10. Baerveldt shunts in the treatment of glaucoma secondary to anterior uveal melanoma and proton beam radiotherapy.
Sharkawi E; Oleszczuk JD; Bergin C; Zografos L
Br J Ophthalmol; 2012 Aug; 96(8):1104-7. PubMed ID: 22628537
[TBL] [Abstract][Full Text] [Related]
11. Proton beam radiotherapy of iris melanoma.
Damato B; Kacperek A; Chopra M; Sheen MA; Campbell IR; Errington RD
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):109-15. PubMed ID: 16111578
[TBL] [Abstract][Full Text] [Related]
12. Ciliary body melanoma with limited nodular extrascleral extension and diffuse iris-angle infiltration treated by whole anterior segment plaque radiotherapy.
Gray ME; Corrêa ZM; Augsburger JJ; Barrett W
Int Ophthalmol; 2007 Aug; 27(4):273-6. PubMed ID: 17468833
[TBL] [Abstract][Full Text] [Related]
13. Proton Therapy for 166 Patients with Iris Melanoma: Side Effects and Oncologic Outcomes.
Gollrad J; Böker A; Vitzthum S; Besserer A; Heufelder J; Gauger U; Böhmer D; Budach V; Zeitz O; Joussen AM
Ophthalmol Retina; 2023 Mar; 7(3):266-274. PubMed ID: 36087876
[TBL] [Abstract][Full Text] [Related]
14. Proton beam therapy for presumed and confirmed iris melanomas: a review of 36 cases.
Rahmi A; Mammar H; Thariat J; Angellier G; Herault J; Chauvel P; Kodjikian L; Denis P; Grange JD
Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1515-21. PubMed ID: 25038910
[TBL] [Abstract][Full Text] [Related]
15. Proton Beam Therapy for Iris Melanomas in 107 Patients.
Thariat J; Rahmi A; Salleron J; Mosci C; Butet B; Maschi C; Lanza F; Lanteri S; Baillif S; Herault J; Mathis T; Caujolle JP
Ophthalmology; 2018 Apr; 125(4):606-614. PubMed ID: 29128229
[TBL] [Abstract][Full Text] [Related]
16. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
[TBL] [Abstract][Full Text] [Related]
17. Plaque radiation therapy for malignant melanoma of the iris and ciliary body.
Finger PT
Am J Ophthalmol; 2001 Sep; 132(3):328-35. PubMed ID: 11530044
[TBL] [Abstract][Full Text] [Related]
18. Conservative management of suspicious melanocytic lesions of the iris.
Oxenreiter MM; Lane AM; Jain P; Kim IK; Gragoudas ES
Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1319-1324. PubMed ID: 30919077
[TBL] [Abstract][Full Text] [Related]
19. Plaque radiotherapy for residual or recurrent iris melanoma after surgical resection in 32 cases.
Shah SU; Shields CL; Bianciotto C; Emrich J; Komarnicky L; Shields JA
Ophthalmology; 2012 Apr; 119(4):838-842.e2. PubMed ID: 22133794
[TBL] [Abstract][Full Text] [Related]
20. Secondary Glaucoma due to Iridescent Crystalline Particles Masquerading as Refractory Hypertensive Uveitis in an Eye With Irradiated Iris Melanoma.
Chahal R; Mohite AA; Heimann H; Bansal A
J Glaucoma; 2018 Apr; 27(4):385-388. PubMed ID: 29394206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
